Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

6.47
Delayed Data
As of 3:15pm ET
 +0.0453 / +0.71%
Today’s Change
2.62
Today|||52-Week Range
7.14
+4.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$83.3M

Company Description

Adamis Pharmaceuticals Corp. is a pharmaceutical company, which engages in the development and commercialization of pharmaceutical products. Its products are concentrated in major therapeutic areas, including oncology, immunology and infectious diseases and allergy and respiratory. The company combines specialty pharmaceuticals and biotechnology to provide medicines for patients, physicians and healthcare organizations. It is focused on the development of preventive and therapeutic vaccine products and cancer drugs for patients with unmet medical needs. Adamis Pharmaceuticals was founded on April 1, 2009 and is headquartered in San Diego, CA.

Contact Information

Adamis Pharmaceuticals Corp.
11455 El Camino Real
San Diego California 92130
P:(858) 997-2400
Investor Relations:
(858) 412-7951

Employees

Shareholders

Individual stakeholders22.08%
Other institutional18.97%
Mutual fund holders1.85%

Top Executives

Dennis J. CarloPresident, Chief Executive Officer & Director
Karen K. DanielsVice President-Operations
Robert O. HopkinsChief Financial Officer, Secretary & VP
Thomas H. MollVice President-Research
David J. MarguglioDirector & Senior VP-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account